Staley Capital Advisers Inc Anixa Biosciences Inc Transaction History
Staley Capital Advisers Inc
- $2.31 Billion
- Q2 2025
A detailed history of Staley Capital Advisers Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Staley Capital Advisers Inc holds 10,000 shares of ANIX stock, worth $48,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$48,500
Previous $28,000
17.86%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.31MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.39MShares$6.76 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.99 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2.98 Million0.01% of portfolio
-
Ubs Group Ag505KShares$2.45 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.79 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $149M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...